In a string of ADC acquisitions, Novartis agreed to acquire Myricx Bio for up to $1.5 billion, gaining an NMTi ADC payload platform designed to overcome resistance in solid tumor treatment.

New Found Gold Corp. today provided an update on the development of the Company's 100% owned flagship Queensway Gold Project ...